HLA-DRB5 and hereditary neurological disease: Regarding cDC1s, the genes associated with MHC II antigen presentation (HLA-DRB5, IFI30), immune activation (NAPSB), and developmental and neurogenetic diseases (NBPF14) were highly expressed in active TAO compared to NCs (Figure 5D, 5E).